Why does Leigh syndrome respond to immunotherapy?

Josef Finsterer; Sinda Zarrouk-Mahjoub

doi:10.1016/j.ymgmr.2016.07.008

Journal Articles Molecular Genetics and Metabolism Reports Year : 2016

Why does Leigh syndrome respond to immunotherapy?

(1) , (2)

1
2

Josef Finsterer

Function : Author
PersonId : 892592

Krankenanstalt Rudolfstiftung

Sinda Zarrouk-Mahjoub

Function : Author

Institut Pasteur de Tunis

Domains

Life Sciences [q-bio]

Fichier principal

1-s2.0-S2214426916300568-main.pdf (150.33 Ko)

Origin : Files produced by the author(s)

Institut Pasteur Tunis : Connect in order to contact the contributor

https://hal-riip.archives-ouvertes.fr/pasteur-01452699

Submitted on : Thursday, February 2, 2017-10:39:08 AM

Last modification on : Monday, October 8, 2018-5:44:08 PM

Dates and versions

pasteur-01452699 , version 1 (02-02-2017)

Identifiers

HAL Id : pasteur-01452699 , version 1
DOI : 10.1016/j.ymgmr.2016.07.008
PUBMED : 28649511
PUBMEDCENTRAL : PMC5470935

Cite

Josef Finsterer, Sinda Zarrouk-Mahjoub. Why does Leigh syndrome respond to immunotherapy?. Molecular Genetics and Metabolism Reports, 2016, 11, pp.90 - 91. ⟨10.1016/j.ymgmr.2016.07.008⟩. ⟨pasteur-01452699⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

RIIP RIIP_TUNIS

57 View

208 Download

Why does Leigh syndrome respond to immunotherapy?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share